November, 2017

article thumbnail

Improving commercial decisions with customer relationship network insights

pharmaphorum

Networks of influence are shifting the decision-making process for life sciences companies. It is no longer enough to simply view the profile of a HCP or HCO to understand their value to your organization. For life sciences organizations, there is currently a gap in information, understanding, and digital access to these critical customer networks and relationships.

52
article thumbnail

NSAID Prescribing Cascade

Med Ed 101

Here’s a case scenario with a primary focus on the NSAID prescribing cascade. A 76 year old male has a past medical history of: COPD CHF Hypertension GERD Osteoarthritis Current medications include: Metoprolol 25 mg BID Lisinopril 10 mg daily Symbicort 160/4.5 two puffs BID Qvar 40 mcg one inhalation twice daily Albuterol 1-2 puffs […]. The post NSAID Prescribing Cascade appeared first on Med Ed 101.

40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The evolution of pharma social media intelligence

pharmaphorum

Is your company a fully mature user of intelligence from social media, or is it still not tapping into insights? As shown in the consumer world, social media can be a very rich source of insights into customers and markets, and can provide early signals of new trends. Exactly the same is true for patient and health care provider insights, especially when used with other more traditional data sets.

article thumbnail

UNLEARN. RELEARN. REIMAGINE. Smarter communications through behavioral science

pharmaphorum

How can we create smarter, more effective communications for HCPs and patients? What can be done to challenge the status quo, apply a different mindset to communications, and deliver the best possible patient outcomes? In this webinar, we will discuss how multichannel strategy and behavioural science are natural partners in creating smarter, more meaningful, and more effective communications.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Improving outcomes through industry partnership - the Cancer Vanguard learnings

pharmaphorum

The Cancer Vanguard is a bold initiative setup to take leadership in the delivery of the National Cancer Strategy – Achieving World-Class Cancer Outcomes published in 2015 with a key aim of designing and implementing new and increasingly patient centric models of care in Cancer that can benefit and be adopted by the wider national cancer system. In summer 2016 the Cancer Vanguard medicines optimisation team launched the ‘Pharma Challenge’ as an opportunity for the pharma and life sciences indust

52
article thumbnail

Antibiotic Stewardship in Long Term Care – Consultant Pharmacist Role

Med Ed 101

Consultant pharmacists play a very important role in long term care. We often support nursing and providers in assurance that medications are used appropriate and safely in our residents. Antibiotic stewardship in long term care is an ever expanding topic and agencies are placing a larger role on consultant pharmacists to do more. The question […].

40

More Trending

article thumbnail

Free SAMPLE! Pharmacotherapy Prep Course from Meded101

Med Ed 101

Our BCPS All Access Pass is now available! You can find it here under the BCPS tab. For now, here’s a free sample of one of the over 100+ videos! The post Free SAMPLE! Pharmacotherapy Prep Course from Meded101 appeared first on Med Ed 101.

40
article thumbnail

Glyburide in Kidney Disease

Med Ed 101

Using glyburide in kidney disease is not recommended. It has a longer half life and may have a little more potent effect in kidney disease. A significant challenge to figure out is if patients are doing well on their current dose, should we change it? In this scenario, patient changes give us the opportunity to […]. The post Glyburide in Kidney Disease appeared first on Med Ed 101.

40
article thumbnail

Should I Take All These Supplements?

Med Ed 101

I often get referrals for patients who have questions about supplements. Some will ask me “Should I take all theses supplements?” There are definitely some scenarios where I think supplements may be a good options and worth taking, but often times I think patients are just wasting their money. Here’s a scenario of a poly-supplement […].

40
article thumbnail

Lithium Caffeine Drug Interaction

Med Ed 101

As a pharmacist, I recognize some of the challenges associated with trying to help patients with their medications. In this scenario, I try to demonstrate the lithium caffeine drug interaction. A 29 year old female has recently started on lithium. She has been stabilized on a total daily dose of 1,500 mg per day. She […]. The post Lithium Caffeine Drug Interaction appeared first on Med Ed 101.

40
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Hormone Replacement Therapy – Patient Discussions

Med Ed 101

Hormone replacement therapy (HRT) is the utilization of hormones (i.e. estrogen) to replace the natural decline in hormones when menopause happens. HRT is very effective a reducing/eliminating the vasomotor symptoms (i.e. hot flashes) associated with menopause. So, how much risk is too much risk? This is always a tough question and there will be patients […].

40